Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the safety and efficacy of NG101 in adults with symptomatic diabetic or idiopathic gastroparesis has completed enrollment and posted re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Gastroparesis
• Idiopathic Gastroparesis

Drugs mentioned

• NG101

Snippet

Sponsor: Neurogastrx, Inc. | Conditions: Diabetic Gastroparesis, Idiopathic Gastroparesis | Phase 2 | Status: COMPLETED | Results posted: 2025-08-28